New Approvals In Spotlight As China Gears For National Congress
Proposed Biosecurity Law Also Gains Momentum
In a sign that attention in China may be shifting back to more routine regulatory work as the local coronavirus outbreak appears to recede, authorities have granted approvals to multiple new drugs for cancer and rare diseases, as the government gears up to hold its delayed annual congress in Beijing.
